Trials / Recruiting
RecruitingNCT07270692
Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Eko Devices, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The main objectives of this study are to train and evaluate an algorithm that predicts whether an individual has an ejection fraction ≤ 40%, using heart sounds and a 3-lead ECG as inputs, as well as determine the impact of gender, age, and race on algorithm performance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Eko digital stethoscopes | Use of the Eko CORE 500 digital stethoscope and 3M Littmann CORE Digital Stethoscope to auscultate and record cardiac phonocardiogram and (when available) electrocardiogram waveforms, as well as heart sounds. |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2026-08-01
- Completion
- 2026-11-01
- First posted
- 2025-12-08
- Last updated
- 2025-12-18
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT07270692. Inclusion in this directory is not an endorsement.